Central Obesity and Recurrent Cardiovascular Events in Patients With Obstructive Sleep Apnea
Weight management alongside sleep apnea treatment protects heart health better than treating sleep apnea alone in at-risk patients.
This RCT-level publication in Neurology establishes central obesity as a primary driver of recurrent major cardiovascular events in obstructive sleep apnea patients, independent of sleep apnea treatment effects. The findings highlight combined weight management and OSA therapy as a superior strategy to cardiometabolic risk reduction compared to OSA treatment alone.
What the study was
- Study design
- Randomized Controlled Trial
- Population
- Patients with obstructive sleep apnea and cardiovascular disease at elevated recurrent event risk
- Category
- Prevention
- Maturity
- Validated
- Journal
- Neurology
Why it surfaced
RCT-level evidence in Neurology linking central obesity to CV recurrence in OSA; large cardiometabolic population with directly actionable obesity management target.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.